Ownership

Decheng Capital Global Life Sciences Fund IV, L.P. - 10%+ Owner at CG Oncology, Inc.

Insider Transactions and Holdings

Entity Type: Company
Role: 10%+ Owner
Stock Symbol: CGON on Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
All Insider Reports: All Insider Reports

There are no Buy or Sell transactions made by Decheng Capital Global Life Sciences Fund IV, L.P. since 3/9/2024

Holdings reported by Decheng Capital Global Life Sciences Fund IV, L.P. for CG Oncology, Inc.

Class	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	4.96M	$175M	$35.36	Jan 29, 2024	Direct
Series C Preferred Stock	0			Jan 29, 2024	Direct	Common Stock
Series E Preferred Stock	0			Jan 29, 2024	Direct	Common Stock
Series F Preferred Stock	0			Jan 29, 2024	Direct	Common Stock

Showing 1 to 4 of 4 entries

Transactions reported by Decheng Capital Global Life Sciences Fund IV, L.P. for CG Oncology, Inc.

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.